menu

The Reality of the Opioid Epidemic and Rising Maternal HCV Rates: What the OB/GYN Needs to Know

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Hot Topics in HCV: A Multidisciplinary Online Minicurriculum - Activity 2: The Dual Realities of the Opioid Epidemic and Rising Maternal HCV Rates: What the OB/GYN Needs to Know!

close
0.25 credits
15
ReachMD Healthcare Image
Restart
Resume
Read full article
Choose a format
Get your free creditsSkip straight to the post-test if you have already participated in this activity
Media formats available:
0.25 credits
A pre-test is required to view this content.
A pre-survey is required to view this content.
Details
Presenters
Comments
  • Overview

    With alarming increases in the incidence of maternal HCV, your obstetrics and gynecology (OB/GYN) practice plays a critical role in screening of all pregnant patients and engaging HCV-infected women who otherwise may not seek medical care. This educational activity will provide practical tactics for implementing Centers for Disease Control and Prevention (CDC) screening guidelines at the practice level, insights for destigmatizing behavioral risk inquiries and harm-reduction discussions, current recommendations for postpartum HCV treatment, and evolving perspectives on HCV treatment during pregnancy.

  • Provider(s)/Educational Partner(s)

    ReachMD Healthcare ImageReachMD Healthcare Image

    This activity is jointly provided by Global Education Group and Integritas Communications.

  • Commercial Support

    This activity is supported by an educational grant from AbbVie Inc.

  • References

    1. Centers for Disease Control and Prevention (CDC). Testing recommendations for hepatitis C virus infection. Last reviewed July 2020. https://www.cdc.gov/hepatitis/hcv/guidelinesc.htm. Accessed July 5, 2021. 
    2. Kushner T, Reau N. Changing epidemiology, implications, and recommendations for hepatitis C in women of childbearing age and during pregnancy. J Hepatol. 2021;74(3):734-741.
  • Target Audience

    The educational design of this activity addresses the needs of obstetricians/gynecologists and other clinicians potentially involved in screening, counseling, or treating hepatitis C virus (HCV).

  • Educational Objective

    After completing this activity, the participant should be better able to:

    • Explain guideline-based HCV testing and proactive counseling for HCV-positive pregnant women
  • Accreditation and Credit Designation Statements

    Physician Accreditation Statement
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Integritas Communications. Global is accredited by the ACCME to provide continuing medical education for physicians. 

    Physician Credit Designation
    Global Education Group designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

    Nursing Continuing Education
    Global Education Group is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

    This educational activity for 0.25 contact hour is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

  • Instructions to Receive Credit

    In order to receive credit for this activity, the participant must review the activity as well as successfully complete the posttest and evaluation form.

  • Term of Offering

    This activity was released on September 30, 2021 and is valid for 1 year. Requests for credit must be made no later than September 30, 2022.

  • Global Contact Information

    For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

  • System Requirements

    PC
    1.4 GHz Intel Pentium 4 or faster processor (or equivalent)
    Windows 10, 8.1 (32-bit/64-bit), Windows 7 (32-bit/64-bit)
    512 MB of RAM (1 GB recommended)
    Microsoft Internet Explorer 11 or later, Windows Edge browser, Mozilla Firefox, and Google Chrome
    For HTML Client – Google Chrome (v70.0 & above), Mozilla Firefox (v65.0 & above), and Edge (v42.0 & above) 

    MAC
    1.83 GHz Intel Core Duo or faster processor
    512 MB of RAM (1 GB recommended)
    MAC OS X 10.12, 10.13 and 10.14
    Mozilla Firefox, Apple Safari, Google Chrome
    For HTML Client – Google Chrome (v70.0 & above), Apple Safari (v12.0 & above), and Mozilla Firefox (v65.0 & above) 

  • Fee Information & Refund/Cancellation Policy

    There is no fee for this educational activity.

  • Disclosure of Conflicts of Interest

    Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global.  All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias. 

    All relevant financial relationships have been mitigated.

    The faculty have the following relevant financial relationships with ineligible companies:

    Name of Faculty or Presenter

    Reported Financial Relationship

    Ricardo Franco, MD

    Consulting Fees: Theratechnologies Inc.

    Contracted Research: AbbVie Inc., Gilead Sciences, Inc., Janssen Pharmaceuticals, Inc., Merck & Co., Inc.

    Catherine A. Chappell, MD, MSc

    Consulting Fees: Gilead Sciences, Inc.

    Contracted Research: Gilead Sciences, Inc., Merck & Co., Inc.

    The planners and managers have the following relevant financial relationships with ineligible companies:

    Name of Planner or Manager

    Reported Financial Relationship

    Rhys Williams, RN, MSN, FNP

    Nothing to disclose

    Lindsay Borvansky

    Nothing to disclose

    Andrea Funk

    Nothing to disclose

    Liddy Knight

    Nothing to disclose

    Ashley Cann

    Nothing to disclose

    Jeanette Ruby, MD

    Nothing to disclose

    Jim Kappler, PhD

    Nothing to disclose

  • Disclosure of Unlabeled Use

    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Global Education Group (Global) and Integritas Communications do not recommend the use of any agent outside of the labeled indications. 

    The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

  • Disclaimer

    Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

  • Publication Dates

    Release Date:

    Expiration Date:

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    With alarming increases in the incidence of maternal HCV, your obstetrics and gynecology (OB/GYN) practice plays a critical role in screening of all pregnant patients and engaging HCV-infected women who otherwise may not seek medical care. This educational activity will provide practical tactics for implementing Centers for Disease Control and Prevention (CDC) screening guidelines at the practice level, insights for destigmatizing behavioral risk inquiries and harm-reduction discussions, current recommendations for postpartum HCV treatment, and evolving perspectives on HCV treatment during pregnancy.

  • Provider(s)/Educational Partner(s)

    ReachMD Healthcare ImageReachMD Healthcare Image

    This activity is jointly provided by Global Education Group and Integritas Communications.

  • Commercial Support

    This activity is supported by an educational grant from AbbVie Inc.

  • References

    1. Centers for Disease Control and Prevention (CDC). Testing recommendations for hepatitis C virus infection. Last reviewed July 2020. https://www.cdc.gov/hepatitis/hcv/guidelinesc.htm. Accessed July 5, 2021. 
    2. Kushner T, Reau N. Changing epidemiology, implications, and recommendations for hepatitis C in women of childbearing age and during pregnancy. J Hepatol. 2021;74(3):734-741.
  • Target Audience

    The educational design of this activity addresses the needs of obstetricians/gynecologists and other clinicians potentially involved in screening, counseling, or treating hepatitis C virus (HCV).

  • Educational Objective

    After completing this activity, the participant should be better able to:

    • Explain guideline-based HCV testing and proactive counseling for HCV-positive pregnant women
  • Accreditation and Credit Designation Statements

    Physician Accreditation Statement
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Integritas Communications. Global is accredited by the ACCME to provide continuing medical education for physicians. 

    Physician Credit Designation
    Global Education Group designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

    Nursing Continuing Education
    Global Education Group is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

    This educational activity for 0.25 contact hour is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

  • Instructions to Receive Credit

    In order to receive credit for this activity, the participant must review the activity as well as successfully complete the posttest and evaluation form.

  • Term of Offering

    This activity was released on September 30, 2021 and is valid for 1 year. Requests for credit must be made no later than September 30, 2022.

  • Global Contact Information

    For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

  • System Requirements

    PC
    1.4 GHz Intel Pentium 4 or faster processor (or equivalent)
    Windows 10, 8.1 (32-bit/64-bit), Windows 7 (32-bit/64-bit)
    512 MB of RAM (1 GB recommended)
    Microsoft Internet Explorer 11 or later, Windows Edge browser, Mozilla Firefox, and Google Chrome
    For HTML Client – Google Chrome (v70.0 & above), Mozilla Firefox (v65.0 & above), and Edge (v42.0 & above) 

    MAC
    1.83 GHz Intel Core Duo or faster processor
    512 MB of RAM (1 GB recommended)
    MAC OS X 10.12, 10.13 and 10.14
    Mozilla Firefox, Apple Safari, Google Chrome
    For HTML Client – Google Chrome (v70.0 & above), Apple Safari (v12.0 & above), and Mozilla Firefox (v65.0 & above) 

  • Fee Information & Refund/Cancellation Policy

    There is no fee for this educational activity.

  • Disclosure of Conflicts of Interest

    Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global.  All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias. 

    All relevant financial relationships have been mitigated.

    The faculty have the following relevant financial relationships with ineligible companies:

    Name of Faculty or Presenter

    Reported Financial Relationship

    Ricardo Franco, MD

    Consulting Fees: Theratechnologies Inc.

    Contracted Research: AbbVie Inc., Gilead Sciences, Inc., Janssen Pharmaceuticals, Inc., Merck & Co., Inc.

    Catherine A. Chappell, MD, MSc

    Consulting Fees: Gilead Sciences, Inc.

    Contracted Research: Gilead Sciences, Inc., Merck & Co., Inc.

    The planners and managers have the following relevant financial relationships with ineligible companies:

    Name of Planner or Manager

    Reported Financial Relationship

    Rhys Williams, RN, MSN, FNP

    Nothing to disclose

    Lindsay Borvansky

    Nothing to disclose

    Andrea Funk

    Nothing to disclose

    Liddy Knight

    Nothing to disclose

    Ashley Cann

    Nothing to disclose

    Jeanette Ruby, MD

    Nothing to disclose

    Jim Kappler, PhD

    Nothing to disclose

  • Disclosure of Unlabeled Use

    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Global Education Group (Global) and Integritas Communications do not recommend the use of any agent outside of the labeled indications. 

    The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

  • Disclaimer

    Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

  • Publication Dates

    Release Date:

    Expiration Date:

Facebook Comments

Schedule20 Oct 2021
Webpack App